Krenitsky Pharmaceuticals
Major Drugs - N/A, N/A, US
Krenitsky Pharmaceuticals Employees
Krenitsky Pharmaceuticals Details
KPI is a clinical-stage biopharma company focused on the development of new medicines that have the potential to transform the standard of care and save or improve patients' lives. Our pipeline includes TriRima, a reversible inhibitor of monoamine oxidase-A (RIMA) for the treatment of depression, and KP544, a novel mechanism for the treatment of neurodegenerative disorders such as Alzheimer's Disease and prevention of neuropathy caused by chemotherapeutic agents.
Website:
kpipharma.com
Employees:
5 - 9
HQ:
N/A
Location:
N/A, N/A, US
Revenue:
Not Available
Krenitsky Pharmaceuticals Technologies
Email Providers
Gmail
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting